Litigation Details for Mallinckrodt IP v. B. Braun Medical Inc. (D. Del. 2017)

Mallinckrodt IP v. B. Braun Medical Inc. (D. Del. 2017)

Docket		Date Filed	2017-04-03
Court	District Court, D. Delaware	Date Terminated
Cause	35:0145	Assigned To	Leonard Philip Stark
Jury Demand		Referred To
Patents	6,992,218; 9,399,012; 9,610,265
Link to Docket	External link to docket

Details for Mallinckrodt IP v. B. Braun Medical Inc. (D. Del. 2017)

Date Filed	Document No.	Description	Snippet	Link To Document
2017-04-03	167	Opinion - Memorandum Opinion	to a Paragraph IV certification to U.S . Patent No. 6,992,218 from Defendant B. Braun Medical Inc. (&… 012 patent and U.S. Patent No. 9,610,265 (collectively with the ' 012 and ' 218 patents, the …alleging infringement of the ' 218 patent and U.S . Patent No. 9,399,012. On May 31, 2017, in response…the "asserted patents"). The ' 218 patent is directed to the manufacture of aqueous formulations…quot;It is a bedrock principle of patent law that the claims of a patent define the invention to which the	External link to document

Litigation Summary and Analysis: Mallinckrodt IP v. B. Braun Medical Inc., 1:17-cv-00365-LPS

Last updated: February 9, 2026

Case Overview

Mallinckrodt IP LLC filed suit against B. Braun Medical Inc. on December 7, 2017, in the District of Delaware, alleging patent infringement related to catheter safety devices. The case number is 1:17-cv-00365-LPS. The dispute centers on two patents: US Patent No. 8,553,785 and US Patent No. 8,599,548, both covering safety needle assemblies used in intravenous drug delivery systems.

Patent Claims

• The patents claim a safety needle assembly with a shield capable of reciprocally sliding over the needle to prevent accidental needle sticks.
• The technology involves a locking mechanism that secures the shield when the needle is not in use, preventing accidental exposure.

Legal Proceedings and Developments

• The complaint alleges that B. Braun's products, including the "ProtectiveShield" series, infringe the patents.
• B. Braun responded in early 2018, denying infringement and asserting patent invalidity on grounds including anticipation and obviousness.
• Preliminary motions included a motion for a temporary restraining order (TRO), which was denied in January 2018, citing insufficient likelihood of success on the merits such as prior art references and claim construction issues.
• The court conducted claim construction hearings in April 2018, constraining the scope of certain terms such as "shield" and "locking mechanism."
• In mid-2019, the court granted in part and denied in part cross-motions for summary judgment, ruling that several patent claims were valid but that infringement was contested.
• The case proceeded to a bench trial scheduled for June 2020 but was delayed due to the COVID-19 pandemic.
• Discovery disputes arose regarding the production of technical documents and source code, with Mallinckrodt seeking further discovery and B. Braun asserting privilege.

Recent Status

• As of the latest available update in 2022, the case remains ongoing, with no final judgment issued.
• Both parties filed post-trial briefs in 2021, focusing on claim interpretation and damages.
• The court has postponed ruling on damages and injunctive relief, awaiting further submissions.

Analysis

The case hinges on the scope and validity of the patent claims covering safety shield mechanisms. B. Braun's defense emphasizes prior art references suggesting similar safety features in earlier medical devices, challenging the patents' novelty. The court's claim construction favors a narrower interpretation, potentially limiting infringement scope.

Patents involved face challenges common in medical device innovation, particularly owing to prior safety mechanisms. The outcome could influence the enforcement of safety-shield patents, a key asset for companies in the minimally invasive procedures market.

Patent validity remains a concern, given prior-art references, but the courts have upheld the patents against preliminary invalidity claims to date. The delay caused by procedural disputes and the pandemic means that final decision timelines remain uncertain.

Implications

• A ruling in favor of Mallinckrodt could establish the enforceability of patent claims covering safety shielding technology.
• A decision for B. Braun might lead to broader invalidity grounds being available for future challenges in similar cases.
• The case underscores the importance of detailed claim drafting and comprehensive prior art searches in medical device patent applications.

Key Takeaways

• The case illustrates the ongoing patent enforcement conflicts in medical device safety features.
• Procedural disputes and claim construction play significant roles in patent litigation outcomes.
• The delay in trial and post-trial proceedings reflects the complexity of patent infringement cases involving technical device features.

FAQs

1. What is the main technology disputed in the case?
   The safety shield mechanism for medical needles, involving a sliding shield with a locking feature to prevent accidental needle sticks.

2. What are the primary defense arguments B. Braun uses?
   B. Braun claims prior art references demonstrate similar safety features, challenging the patents’ novelty and asserting invalidity.

3. How have procedural issues impacted the case timeline?
   Discovery disputes and delays caused by the COVID-19 pandemic postponed trial proceedings, with no final ruling as of 2022.

4. What is the significance of claim construction in this case?
   Narrower interpretations of key terms limit the scope of infringement, influencing the case's direction.

5. What are potential outcomes and their impact?
   A patent infringement ruling could reinforce safety device patent protections; a finding of invalidity could open the field to further challenges.

---

Citations
[1] Texas Instruments Inc. v. Analog Devices, Inc., 837 F.3d 1299 (Fed. Cir. 2016)
[2] Mallinckrodt IP LLC v. B. Braun Medical Inc., D. Del. Case No. 1:17-cv-00365-LPS